News
A series of digital tests carried out via a smartphone app could enhance the detection of disease progression in Huntington's ...
Ibogaine is illegal in the United States, but Texas is on the verge of spending up to $50 million to jumpstart clinical ...
A "sub-study" of a late-stage clinical trial found the drug, obicetrapib, significantly reduced levels of a certain type of ...
The research shown that Trametinib alone was able to extend the lifespan of mice by between five and 10 percent, while ...
Shares of weight-loss drug developer Metsera gained as much as 25% on Monday after the company's experimental drug helped patients lose weight in a small, early-stage trial, showing potential for a ...
TuHURA Biosciences said its carcinoma therapy trials can continue now that health regulators have removed the partial clinical hold on the treatment tests.
AI startup ByteBrain is transforming clinical trials with agent-based optimization, cutting costs, boosting efficiency, and ...
A Melbourne laboratory is successfully growing mini tumours from patients’ own cancer cells in a bid to ensure women get ...
Metsera’s obesity drug candidate targeting the amylin hormone showed marked efficacy in an early trial, the company said ...
Axsome Therapeutics has hit a costly snag in its mission to bring esreboxetine to market for fibromyalgia. | Axsome ...
4h
ABC13 Houston on MSNUS Food and Drug Administration to review injectable medication to prevent HIV transmissionThe medication, Lenacapavir, is said to have shown exceptional promise in clinical trials, and some of the research is being conducted here in Houston.
Metsera, the obesity-focused biotech, said this morning that its drug candidate targeting the amylin hormone showed marked ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results